We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHEF icon
301
Chefs' Warehouse
CHEF
$4.34B
$31.3M 0.07%
801,278
-3
-0% -$111
BAP icon
302
Credicorp
BAP
$29.6B
$31.3M 0.07%
194,088
-1,303
-0.7% -$216K
VRNA
303
DELISTED
Verona Pharma
VRNA
$31.3M 0.07%
2,163,600
-95,000
-4% -$1.39M
NEM icon
304
Newmont
NEM
$131B
$30.9M 0.07%
739,183
-103,684
-12% -$4.24M
YETI icon
305
Yeti Holdings
YETI
$2.88B
$30.7M 0.07%
805,565
-107,806
-12% -$4.2M
AXTA icon
306
Axalta
AXTA
$7.12B
$30.6M 0.07%
896,188
+25,717
+3% +$879K
MUSA icon
307
Murphy USA
MUSA
$9.67B
$30.4M 0.07%
64,726
-30,598
-32% -$13.3M
NVO
308
Novo Nordisk
NVO
$188B
$29.9M 0.07%
209,711
-12,742
-6% -$1.69M
ACM icon
309
Aecom
ACM
$8.26B
$29.9M 0.07%
339,563
-36,386
-10% -$3.32M
ELAN icon
310
Elanco Animal Health
ELAN
$11.5B
$29.8M 0.07%
2,066,277
+30,434
+1% +$486K
CNC icon
311
Centene
CNC
$33.4B
$29.7M 0.07%
448,211
+1,096
+0.2% +$79.7K
CVS icon
312
CVS Health
CVS
$121B
$29.6M 0.07%
501,984
+215,024
+75% +$13.5M
C icon
313
Citigroup
C
$228B
$29.6M 0.07%
465,849
-20,423
-4% -$1.26M
EME icon
314
Emcor
EME
$32.4B
$29.5M 0.07%
80,790
-10,057
-11% -$3.71M
EBAY icon
315
eBay
EBAY
$48.1B
$29.4M 0.07%
547,517
+164,282
+43% +$8.56M
KKR icon
316
KKR & Co
KKR
$89.8B
$29.3M 0.07%
278,309
+34,201
+14% +$3.48M
NXT icon
317
Nextpower Inc. Common Stock
NXT
$12.1B
$29M 0.07%
618,353
-123,921
-17% -$6.16M
DPZ icon
318
Domino's
DPZ
$10.3B
$28.7M 0.07%
55,541
+27,245
+96% +$13.9M
XENE icon
319
Xenon Pharmaceuticals
XENE
$5.45B
$28.6M 0.07%
734,555
-345
-0% -$13.8K
ICE icon
320
Intercontinental Exchange
ICE
$88.1B
$28.5M 0.07%
208,078
+12,526
+6% +$1.68M
GEV icon
321
GE Vernova
GEV
$235B
$28.4M 0.07%
+165,715
New +$26.3M
CNP icon
322
CenterPoint Energy
CNP
$25B
$28.3M 0.07%
912,284
-3,780
-0.4% -$112K
HPE icon
323
Hewlett Packard
HPE
$74.2B
$27.7M 0.07%
1,309,064
+3,082
+0.2% +$56.8K
DAL icon
324
Delta Air Lines
DAL
$51.9B
$27.4M 0.06%
577,269
-7,730
-1% -$385K
MOH icon
325
Molina Healthcare
MOH
$10.8B
$27.3M 0.06%
91,961
+2,323
+3% +$789K

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.